VentureBeat May 7, 2024
Dean Takahashi

Neurable raised $13 million for its brain-computer interface (BCI) technology that can work with everyday products.

Boston-based Neurable plans to use this funding round to advance its platform technology with a range of large-scale applications through its BCI AI technology and scaling its licensing business to further development and experimentation across multiple industries

Neurable wants to democratize neurotechnology. The funding came from Ultratech Capital Partners, TRAC, Pace Ventures, and Metaplanet.

With over $30 million raised since its founding, Neurable is working with its licensing partnership network to make easy-to-use neurotechnology a reality, including through the upcoming launch of the Neurable AI-powered MW75 Neuro headphones.

With this new funding, Neurable will continue to expand the build of its platform, giving companies...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Investments, Medical Devices, Trends
This year's top congressional medical technology priorities
Boston Scientific to acquire devicemaker: 3 things to know
Everything You Need To Know Before Getting An RFID Implant - 3
State Licensing Spotlight - Prescription medical device manufacturers & distributors: Regulatory considerations applicable to medical devices versus drugs
Boston Scientific to buy Sonivie for up to $540M

Share This Article